CLINICAL_TRIALS trial_result · 2025-09-30

Clinical Trial Update: De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma [Phase 2]

Phase 2 trial results discuss de-escalation radiotherapy in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Canadian Cancer Trials Group | Conditions: Oropharyngeal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-30